pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,723 catalysts · 5,720 phase readout · 2,353 8k filing · 258 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 0 catalysts2026-08-05: 0 catalysts2026-08-06: 164 catalysts2026-08-07: 2 catalysts2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 6 catalysts2026-08-11: 4 catalysts2026-08-12: 8 catalysts2026-08-13: 6 catalysts2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 2 catalysts2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 1 catalyst2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 5 catalysts2026-10-28: 6 catalysts2026-10-29: 13 catalysts2026-10-30: 3 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: pdufa×type: phase readout×type: recall×clear all
type
  • phase readout5,720
  • 8k filing2,353
  • earnings258
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07235371: Transcutaneous Electrical Acupoint Stimulation for Postoperative Urinary Retention After Radical Surgery for Cervical Cancer

Sponsor: Lu Chao. Phase: NA. Conditions: Postoperative Urinary Retention (POUR)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07435571: Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of Trapeziometacarpal Osteoarthritis

Sponsor: TBF Genie Tissulaire. Phase: PHASE2. Conditions: Trapeziometacarpal Osteoarthritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT04119544: Mirror Therapy Rehabilitation of the Upper Limb After Stroke (NEURO-MIROIR 2)

Sponsor: Clinique Les Trois Soleils. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06892444: Sweet Corn and Carotenoids

Sponsor: University of Florida. Phase: NA. Conditions: Carotenoids

full page →ctgov ↗
›COMPLETEDphase readoutNCT01129544: Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector

Sponsor: David Williams. Phase: PHASE1. Conditions: Severe Combined Immunodeficiency

full page →ctgov ↗
›RECRUITINGphase readoutNCT07468734: Shock Wave Versus Traditional Physical Therapy for Adult Chronic Knee Osteoarthritis

Sponsor: German International University. Phase: NA. Conditions: Shock Wave, Traditional Physical Therapy, Chronic Knee Osteoarthritis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07414134: Exacerbations and Real-World Outcomes Among Patients With Chronic Obstructive Pulmonary Disease Following Severe Exacerbation

Sponsor: AstraZeneca. Phase: . Conditions: Chronic Obstructive Pulmonary Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT07008209: Comparing the Effectiveness of Reappraisal Strategies in Adult Participants

Sponsor: Ibn Haldun University. Phase: NA. Conditions: Emotional Dysregulation, Anxiety, Sadness, Anxiety Disorders and Symptoms, Depressive Symptoms

full page →ctgov ↗
›COMPLETEDphase readoutNCT06579209: NAD+ Oral Supplement Pilot Intervention in Adult Females

Sponsor: University of Rhode Island. Phase: NA. Conditions: Cognitive Change, Inflammation, Neurodegenerative Diseases

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07231809: Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients

Sponsor: AC.TA. S.r.l.. Phase: NA. Conditions: Non Muscle Invasive Bladder Cancer, Bladder Cancer, Carcinoma in Situ of Bladder, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Bladder

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07643909: Health-Related Social Needs Food Boxes Delivery Program

Sponsor: Boston Medical Center. Phase: NA. Conditions: Food Insecurity

full page →ctgov ↗
›RECRUITINGphase readoutNCT03538899: Autologous Gene Therapy for Artemis-Deficient SCID

Sponsor: University of California, San Francisco. Phase: PHASE1. Conditions: Severe Combined Immunodeficiency

full page →ctgov ↗
›RECRUITINGphase readoutNCT07372898: Impact of Hospital to Home: Optimizing Preterm Infant Environment for Surgical Neonates and Their Parents (H-HOPE)

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago. Phase: NA. Conditions: Oral Feeding Outcomes, Neurodevelopment Outcome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07467798: A Proof-of-concept Study of Ultrasound Stimulation of the Neck to Enhance Anti-shock Efficacy

Sponsor: Tao Liu. Phase: NA. Conditions: Shock

full page →ctgov ↗
›RECRUITINGphase readoutNCT07527663: GyroStim for Post Concussion Syndrome

Sponsor: Neuroscience Group. Phase: NA. Conditions: Post Concussion Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT04384263: The Influence of Tai Chi Practice on Blood Pressure and Brain Health Among Older Adults With Hypertension (ACTION)

Sponsor: University of Connecticut. Phase: NA. Conditions: Hypertension, Cognitive Decline

full page →ctgov ↗
›RECRUITINGphase readoutNCT07313293: Impact of Foot Reflexology on Nausea After Obesity Surgery

Sponsor: Centre Hospitalier Departemental Vendee. Phase: NA. Conditions: Sleeve Gastrectomy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07271693: A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7806881 in Healthy Participants

Sponsor: Hoffmann-La Roche. Phase: PHASE1. Conditions: Healthy Volunteers

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07460921: The Effect of Podcast Education on Postpartum Depression, Maternal Attachment, and Self-Care Agency in the Early Postpartum Period: A Randomized Controlled Trial

Sponsor: Saglik Bilimleri Universitesi. Phase: NA. Conditions: Podcast, Postpartum Woman

full page →ctgov ↗
›COMPLETEDphase readoutNCT00920621: Randomized Trial: Maternal Vitamin D Supplementation to Prevent Childhood Asthma (VDAART)

Sponsor: Brigham and Women's Hospital. Phase: PHASE3. Conditions: Asthma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06088121: Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia

Sponsor: Advanced Technology & Communications. Phase: NA. Conditions: Alzheimer's Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06821321: Power or Plyometric Training in Older Adults

Sponsor: University of Miami. Phase: NA. Conditions: Activity, Motor

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03570021: ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris. Phase: PHASE3. Conditions: Thyroid Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07424521: Psychosocial Effects of Mindfulness-Based Exercise in Postmenopausal Women

Sponsor: Halic University. Phase: NA. Conditions: Psychosocial Functioning, Mindfulness, Postmenopausal Symptoms

full page →ctgov ↗
›TERMINATEDphase readoutNCT02628314: Reliability of Pupil Response to Acute Pain

Sponsor: Wake Forest University Health Sciences. Phase: . Conditions: Pain, Osteoarthritis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07681414: ctDNA Assessment in Endometrial Cancer for Adjuvant Therapy

Sponsor: Guizhou Provincial People's Hospital. Phase: . Conditions: Endometrial Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07658014: Occult Vasoplegia in Normotensive Sepsis: Early Prediction With Diastolic Index and Lactate

Sponsor: Hospital H+ Queretaro. Phase: . Conditions: Sepsis, Vasoplegia, Septic Shock

full page →ctgov ↗
›RECRUITINGphase readoutNCT06711016: Target-directed Management of Cerebral Oxygenation in Patients After Receiving ECPR

Sponsor: Qilu Hospital of Shandong University. Phase: NA. Conditions: Cardiac Arrest

full page →ctgov ↗
›COMPLETEDphase readoutNCT02721316: Outpatient Nurse Monitoring Under the Prevention of Recurrent Suicidal

Sponsor: University Hospital, Montpellier. Phase: NA. Conditions: Mood Disorder, Reactive Depression

full page →ctgov ↗
›COMPLETEDphase readoutNCT05360706: Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B

Sponsor: CSL Behring. Phase: . Conditions: Hemophilia B

full page →ctgov ↗
›RECRUITINGphase readoutNCT07142304: The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study

Sponsor: Luminate Medical, Inc.. Phase: NA. Conditions: Chemotherapy Induced Peripheral Neuropathy (CIPN)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07159204: Polymeric Micellar Paclitaxel-Based Combination Therapy for Advanced Biliary Tract Cancer

Sponsor: Peking Union Medical College Hospital. Phase: PHASE2. Conditions: Biliary Tract Cancer (BTC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06899204: Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.

Sponsor: Pfizer. Phase: . Conditions: Atopic Dermatitis, Atopic Dermatitis, Unspecified, Dermatitis, Atopic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07720804: Kinetics of C-Reactive Protein in Giant Cell Arteritis Following Glucocorticoid Initiation: A Pilot Study (GIDEON)

Sponsor: University Hospital, Limoges. Phase: NA. Conditions: Giant Cell Arteritis (GCA)

full page →ctgov ↗
›COMPLETEDphase readoutNCT03455504: Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leukemia

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto. Phase: PHASE2. Conditions: Acute Myeloid Leukemia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02131584: Ruxolitinib Phosphate in Reducing Fatigue in Patients With Chronic Lymphocytic Leukemia

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Chronic Lymphocytic Leukemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT04563884: Validity of the French Version of Deafness Questionnaires for Children and Adolescents

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Deafness

full page →ctgov ↗
›COMPLETEDphase readoutNCT03413384: To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia

Sponsor: BrainX Corporation. Phase: PHASE2. Conditions: Parkinson's Disease Dementia

full page →ctgov ↗
›COMPLETEDphase readoutNCT04494984: A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.

Sponsor: Inmunova S.A.. Phase: PHASE2. Conditions: COVID-19

full page →ctgov ↗
›RECRUITINGphase readoutNCT07453784: Study to Evaluate Pharmacokinetics, Relative Bioavailability, Palatability of Obefazimod Minitablet Formulation

Sponsor: Abivax S.A.. Phase: PHASE1. Conditions: Healthy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07456384: Sensory Stimulation Program Delivered by Family Members of Brain-injured Patients in Critical Care: Effect on Relatives' Post-traumatic Stress

Sponsor: CHU de Reims. Phase: NA. Conditions: Stress Disorder, Post-traumatic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07679633: App-based Motor Skills Intervention in Primary School and Home Settings

Sponsor: Tampere University. Phase: NA. Conditions: Healthy, Motor Activity

full page →ctgov ↗
›COMPLETEDphase readoutNCT07674472: Impact of Climate Change Education on Nursing Students' Awareness

Sponsor: Koç University. Phase: . Conditions: Climate Change, Nursing Education, Peer Counseling

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07456839: A Mutiple-dose Study of IBI3033 in Healthy Participants

Sponsor: Innovent Biologics (Suzhou) Co. Ltd.. Phase: PHASE1. Conditions: Healthy Participants

full page →ctgov ↗
›COMPLETEDphase readoutNCT07333157: Effects of Wearable Passive Back Support Suit on Back Pain in Caregivers

Sponsor: Samsung Medical Center. Phase: NA. Conditions: Back Pain, Exoskeleton Device

full page →ctgov ↗
›COMPLETEDphase readoutNCT06990828: Frenkel Exercises in Geriatric Balance and Fall Prevention

Sponsor: Okan University. Phase: NA. Conditions: Healthy Aging

full page →ctgov ↗
›COMPLETEDphase readoutNCT04557228: ADAM17 and Vascular Function in Diabetes

Sponsor: University of Missouri-Columbia. Phase: NA. Conditions: Diabetes Mellitus, Type 2

full page →ctgov ↗
›RECRUITINGphase readoutNCT05925465: Maxillary and Mandibular Nerve Block

Sponsor: Mansoura University. Phase: NA. Conditions: Analgesia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06367465: Feasibility and Acceptability of HCV Treatment in Pregnancy

Sponsor: Washington University School of Medicine. Phase: . Conditions: Hepatitis C, Pregnancy Complications

full page →ctgov ↗
›RECRUITINGphase readoutNCT07495865: Post-market Clinical Follow-up (PMCF) Study of Safety and Performance of 502-01 AnGelHA 2

Sponsor: Glyance. Phase: . Conditions: Wrinkles

full page →ctgov ↗
← prev
page 114 of 115
next →